4//SEC Filing
EDWARDS MARK G 4
Accession 0001209191-18-058807
CIK 0001427925other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:35 PM ET
Size
4.9 KB
Accession
0001209191-18-058807
Insider Transaction Report
Form 4
EDWARDS MARK G
Director
Transactions
- Purchase
Common Stock
2018-11-15$2.82/sh+20,700$58,376→ 181,000 total
Footnotes (1)
- [F1]The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.809 to $2.83 on November 15, 2018. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001190429
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:35 PM ET
- Size
- 4.9 KB